White coat hypertension: understanding the concept and examining the significance

被引:10
作者
Tsai, PS
机构
[1] Univ Florida, Coll Nursing, Gainesville, FL 32610 USA
[2] Taipei Med Univ, Taipei, Taiwan
关键词
target-organ damage; white coat effect; white coat hypertension;
D O I
10.1046/j.1365-2702.2002.00660.x
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Because the concept of white coat hypertension is evolving, a variety of definitions appear in the literature. There has also been continuing debate as to whether white coat hypertension is a benign clinical condition or is associated with increased hypertensive complications. This paper summarizes and evaluates the literature on white coat effect/hypertension, with a focus on the following aspects of the concepts: (1) alternative definitions, (2) prevalence and predictors, (3) prognostic significance, and (4) implications for clinical practice. The evidence suggests that white coat hypertension is not a harmless phenomenon. It is frequently associated with increased target-organ damage and often coexists with other cardiovascular risk factors. The extent of the presence of other risk factors may determine the risks associated with white coat hypertension. It is important for clinicians to understand the concept, learn to diagnose it properly, and develop strategies for evaluating risk levels so that patients receive the proper treatment.
引用
收藏
页码:715 / 722
页数:8
相关论文
共 24 条
[1]  
BIRKENHAGER WH, 1992, J CARDIOVASC PHARM, V19, pS43
[2]   IS WHITE COAT HYPERTENSION ASSOCIATED WITH ARTERIAL-DISEASE OR LEFT-VENTRICULAR HYPERTROPHY [J].
CAVALLINI, MC ;
ROMAN, MJ ;
PICKERING, TG ;
SCHWARTZ, JE ;
PINI, R ;
DEVEREUX, RB .
HYPERTENSION, 1995, 26 (03) :413-419
[3]   High prevalence of cardiac and extracardiac target organ damage in refractory hypertension [J].
Cuspidi, C ;
Macca, G ;
Sampieri, L ;
Michev, I ;
Salerno, M ;
Fusi, V ;
Severgnini, B ;
Meani, S ;
Magrini, F ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2001, 19 (11) :2063-2070
[4]  
Friedman LawrenceM., 1998, Fundamentals of Clinical Trials, VThird
[5]   WHITE COAT VERSUS SUSTAINED BORDERLINE HYPERTENSION IN TECUMSEH, MICHIGAN [J].
JULIUS, S ;
MEJIA, A ;
JONES, K ;
KRAUSE, L ;
SCHORK, N ;
VANDEVEN, C ;
JOHNSON, E ;
PETRIN, J ;
SEKKARIE, MA ;
KJELDSEN, SE ;
SCHMOUDER, R ;
GUPTA, R ;
FERRARO, J ;
NAZZARO, P ;
WEISSFELD, J .
HYPERTENSION, 1990, 16 (06) :617-623
[6]   Difference between office and ambulatory blood pressure or real white coat effect: does it matter in terms of prognosis? [J].
Lantelme, P ;
Milon, H ;
Vernet, M ;
Gayet, C .
JOURNAL OF HYPERTENSION, 2000, 18 (04) :383-389
[7]  
MacDonald MB, 1999, CAN MED ASSOC J, V161, P265
[8]  
MANCIA G, 1983, LANCET, V2, P695
[9]   Frequency and determinants of white coat hypertension in mild to moderate hypertension -: A primary care based study [J].
Martínez, MA ;
García-Puig, J ;
Martín, JC ;
Guallar-Castillón, P ;
de Cárcer, AA ;
Torre, A ;
Armada, E ;
Nevado, A ;
Madero, RS .
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (03) :251-259
[10]   White-coat hypertension and carotid artery atherosclerosis - A matching study [J].
Muldoon, MF ;
Nazzaro, P ;
Sutton-Tyrrell, K ;
Manuck, SB .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) :1507-1512